Assessing aberrant drug-taking behaviors in the patient with chronic pain
- 126 Downloads
Tremendous progress has been made in the study and treatment of pain in the past two decades. The growing problem of prescription drug abuse has forced the field to take a new look at opioid prescribing and to seek balance between its risks and benefits. Every pain clinician must become better acquainted with the principles of addiction medicine as they apply to pain management. The assessment of aberrant behaviors in patients with chronic pain is one key aspect of mastering these principles.
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 3.Osterweis M, Kleinman A, Mechanic D: Pain and Disability: Clinical, Behavioral, and Public Policy Perspectives [Report of the Committee on Pain, Disability, and Chronic Illness Behavior, Institute of Medicine, National Academy of Sciences]. Washington, DC: National Academy Press: 1987.Google Scholar
- 6.Lee LE Jr: Medications in the control of pain in terminal cancer, with reference to the study of newer synthetic analgesics. JAMA 1941, 116:217.Google Scholar
- 12.Hays L, Kirsh KL, Passik SD: Seeking drug treatment for oxycontin abuse: a chart review of consecutive admissions to a substance abuse treatment facility in the bluegrass region of Kentucky. J Nal Compr Can Network, 2003, 1(3):423–428. This article outlines the abuse patterns and characteristics of users in Kentucky during the height of the OxyContin abuse phenomenon.Google Scholar
- 13.Passik SD, Kirsh KL, Hays L, Crown L: An investigation of the use and abuse of prescription opioids among substance abusers seeking admission to a drug and alcohol rehabilitation program. In preparation.Google Scholar
- 15.Federation of State Medical Boards: Model guidelines for the use of controlled substances for the treatment of pain. House of Delegates of the Federation of State Medical Boards of the United States, April 1998. http://www.fsmb.org. Accessed March 2004.Google Scholar
- 17.Passik SD, Kirsh KL, Whitcomb LA, et al.: A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clin Ther 2004, 26:552–561. This article describes the development of a toll to assess multiple domains of outcome in chronic opioid therapy.PubMedCrossRefGoogle Scholar
- 19.Portenoy RK: Opioid therapy for chronic nonmalignant pain and current status. In Pain Research and Management, vol 1. Edited by Fields HL, Liebeskind JC. Seattle: IASP Press; 1994:247–287.Google Scholar
- 20.Passik SD, Portenoy RK: Substance abuse issues in palliative care. In Principles and Practice of Supportive Oncology. Edited by Berger A, Portenoy RK, Weissman DE. Philadelphia: Lippincott-Raven Publishers; 1998:513–524.Google Scholar
- 28.U.S. Dept. Health & Human Services/SAMHSA/OAS: Emergency Department Trends From the Drug Abuse Warning Network, Final Estimates 1994–2001. Pub D-21, August 2002.Google Scholar
- 29.Katz N, Fanciullo GJ: Role of urine toxicology testing in the management of chronic opioid therapy. Clin J Pain 2002, 18(suppl 4):S76-S82. This article describes the results of urine toxicology screening in patients with and without evidence of noncompliance with opioid therapy.PubMedCrossRefGoogle Scholar